2018
DOI: 10.20892/j.issn.2095-3941.2018.0009
|View full text |Cite
|
Sign up to set email alerts
|

Ovarian cancer presenting with hypercalcemia: two cases with similar manifestations but different mechanisms

Abstract: Hypercalcemia presenting in ovarian cancer is uncommon in the clinic. Here, two cases of ovarian epithelial carcinoma that presented with severe hypercalcemia were reported, with a review of the literature. The laboratory findings and stepwise clinical investigations of these two cases differed, indicating distinct underlying causes of hypercalcemia. In case one, the serum levels and immunostaining for parathyroid hormone-related protein (PTHrP) verified humoral hypercalcemia of malignancy (HHM). In case two, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…The mechanisms of MAHC include HHM (humoral hypercalcemia in malignancy), primary or secondary hyperparathyroidism, osteolytic hypercalcemia, and vitamin D secreting lymphomas [4]. HHM, which is related to malignant tumor cell secretion of PTH-rP, is the most common cause of MAHC [2].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The mechanisms of MAHC include HHM (humoral hypercalcemia in malignancy), primary or secondary hyperparathyroidism, osteolytic hypercalcemia, and vitamin D secreting lymphomas [4]. HHM, which is related to malignant tumor cell secretion of PTH-rP, is the most common cause of MAHC [2].…”
Section: Discussionmentioning
confidence: 99%
“…MAHC can be classified into four types; humoral hypercalcemia of malignancy (HHM), primary or ectopic hyperparathyroidism, osteolytic hypercalcemia, and vitamin D secreting lymphomas [4]. Since the etiology of hypercalcemia is different for each of the four types, the correct differential diagnosis of hypercalcemia is essential to ensure correct treatment.…”
Section: Introductionmentioning
confidence: 99%
“…A quick Google search identifies several case reports describing hypercalcemia associated with parathyroid hormone in women with ovarian cancer, including a high-profile study by Nussbaum and colleagues [17] and a more recent one by Ma and colleagues [18]. These findings provide validation of TranQL and further suggest avenues for exploratory drug discovery in the treatment of ovarian cancer.…”
Section: Use Casementioning
confidence: 94%